Back

Usefulness of late gadolinium enhancement cardiac magnetic resonance to predict appropriate therapies in implantable cardioverter defibrillator patients in primary prevention

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Ventricular Arrhythmias and Sudden Cardiac Death (SCD) ePosters Pathophysiology and Mechanisms ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Paula Sanchez Somonte

University Hospital de Girona Dr. Josep Trueta, Girona (Spain)

34 More presentations in this session

Presentation thumbnail
Incidence of sudden cardiac death after heart transplantation
Doctor G. Bonnet (Bordeaux, FR)
Abstract Slides
Presentation thumbnail
Idiopathic HFrEF. Is there room left for defibrillators?
Doctor F. Fernandes Gama (Carnaxide, PT)
Abstract Slides
Presentation thumbnail
Novel plasma biomarkers in arrhythmogenic cardiomyopathy: The role of ST2 and GDF-15 in predicting biventricular involvement
Doctor D. Akdis (Zurich, CH)
Abstract Slides
Presentation thumbnail
Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy
Doctor N. Parashar (Delhi, IN)
Abstract Slides
Presentation thumbnail
Arrhythmogenic cardiomyopathy is characterized by apex-to-base heterogeneity of right ventricular myocardial contractility and stiffness: an imaging-based patient-specific modeling study
Mr N. van Osta (Maastricht, NL)
Abstract Slides

Access the full session

Session thumbnail
Ventricular Arrhythmias and Sudden Cardiac Death (SCD) ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Congress Session
The storm will pass…
thumbnail
Webinar
The role of cardiac magnetic resonance for patients with ventricular arrhythmias and the prevention of sudden cardiac death in light of the 2022 ESC Guidelines

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources